Evaluation of the ENPP1 and PLIN single nucleotide polymorphisms with type 2 diabetes in a taiwanese population: Evidence for replication and gene-gene interaction

Journal of Investigative Medicine

Volumn 60, Issue 8, 2012, Pages 1169-1173

  Wang, Chun Hsiang ^a   Ke, Wan Sheng ^b   Lin, Eugene ^c,d  

^a TAINAN MUNICIPAL HOSPITAL   (Taiwan)

^b KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d VITA GENOMICS INC   (Taiwan)

Author keywords

Gene gene interactions; Single nucleotide polymorphisms; T2D susceptibility gene; Type 2 diabetes

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; ECTONUCLEOTIDE PYROPHOSPHATASE 1 GENE; FEMALE; GENE INTERACTION; GENE LOCUS; GENE REPLICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERILIPIN GENE; RISK FACTOR; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; GENE FREQUENCY; MIDDLE AGED; MULTIFACTOR DIMENSIONALITY REDUCTION; SEX DIFFERENCE; TAIWANESE;

ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; PERILIPIN; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

EID: 84872301586     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3182746498     Document Type: Article

References (40)

1. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365:1333-1346.
2. Hattersley AT, Pearson ER. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology. 2006;147:2657-2663.
3. Chang CH, Shau WY, Jiang YD, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med. 2010;27:636-643.
4. Owen KR, McCarthy MI. Genetics of type 2 diabetes. Curr Opin Genet Dev. 2007;17:239-244.
5. Doria A, Patti ME, Kahn CR. The emerging genetic architecture of type 2 diabetes. Cell Metab. 2008;8:186-200.
6. Bell JT, Wallace C, Dobson R, et al. Two-dimensional genome-scan identifies novel epistatic loci for essential hypertension. Hum Mol Genet. 2006;15:1365-1374.
7. Carlborg O, Haley CS. Epistasis: too often neglected in complex trait studies. Nat Rev Genet. 2004;5:618-625.
8. Lin E, Hwang Y, Liang KH, et al. Pattern-recognition techniques with haplotype analysis in pharmacogenomics. Pharmacogenomics. 2007;8:75-83.
9. Lin E, Hwang Y, Chen EY. Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C. Pharmacogenomics. 2007;8:1327-1335.
10. Lin E, Hsu SY. A Bayesian approach to gene-gene and gene-environment interactions in chronic fatigue syndrome. Pharmacogenomics. 2009;10:35-42.
11. Qi L, van Dam RM, Asselbergs FW, et al. Gene-gene interactions between HNF4A and KCNJ11 in predicting type 2 diabetes in women. Diabet Med. 2007;24:1187-1191.
12. Neuman RJ, Wasson J, Atzmon G, et al. Gene-gene interactions lead to higher risk for development of type 2 diabetes in an Ashkenazi Jewish population. PLoS One. 2010;5:e9903.
13. Morcillo S, Cardona F, Rojo-Martínez G, et al. Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). Clin Endocrinol (Oxf). 2008;68:102-107.
14. Keshavarz P, Inoue H, Nakamura N, et al. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes. Mol Genet Metab. 2008;93:200-209.
15. Cauchi S, Meyre D, Durand E, et al. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One. 2008;3:e2031.
16. Qu L, He B, Pan Y, et al. Association between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han population. Diabetes Res Clin Pract. 2011;91:171-176.
17. Lou XY, Chen GB, Yan L, et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet. 2007; 80:1125-1137.
18. Lin E, Hong CJ, Hwang JP, et al. Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression. Rejuvenation Res. 2009; 12:387-393.
19. Wu LS, Hsieh CH, Pei D, et al. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant. 2009;24:3360-3366.
20. Lin E, Pei D, Huang YJ, et al. Gene-gene interactions among genetic variants from obesity candidate genes for nonobese and obese populations in type 2 diabetes. Genet Test Mol Biomarkers. 2009;13:485-493.
21. Lin E, Chen PS, Chang HH, et al. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1167-1172.
22. Hamaguchi K, Terao H, Kusuda Y, et al. The PC-1 Q121 allele is exceptionally prevalent in the Dominican Republic and is associated with type 2 diabetes. J Clin Endocrinol Metab. 2004;89:1359-1364.
23. Abate N, Chandalia M, Satija P, et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes. 2005;54:1207-1213.
24. Meyre D, Bouatia-Naji N, Tounian A, et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet. 2005;37:863-867.
25. Bouhaha R, Meyre D, Kamoun HA, et al. Effect of ENPP1/PC-1-K121Q and PPARgamma-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population. Diabetes Res Clin Pract. 2008;81:278-283.
26. Duggirala R, Blangero J, Almasy L, et al. A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans. Am J Hum Genet. 2000;66:1237-1245.
27. Mori Y, Otabe S, Dina C, et al. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate loci on 7p and 11p. Diabetes. 2002;51:1247-1255.
28. Kang ES, Cha BS, Kim HJ, et al. The 11482G 9A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes. Diabetes Care. 2006;29:1320-1324.
29. Qi L, Zhang C, Greenberg A, et al. Common variations in perilipin gene, central obesity, and risk of type 2 diabetes in US women. Obesity (Silver Spring). 2008;16:1061-1065.
30. Gordon D, Finch SJ, Nothnagel M, et al. Power and sample size calculations for case-control genetic association tests when errors present: application to single nucleotide polymorphisms. Hum Hered. 2002;54:22-33.
31. Gordon D, Levenstien MA, Finch SJ, et al. Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case-control association studies. Pac Symp Biocomput. 2003;4:90-501.
32. Pizzuti A, Frittitta L, Argiolas A, et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes. 1999;48:1881-1884.
33. Grarup N, Urhammer SA, Ek J, et al. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia. 2006;49:2097-2104.
34. Weedon MN, Shields B, Hitman G, et al. No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians. Diabetes. 2006;55:3175-3179.
35. Lyon HN, Florez JC, Bersaglieri T, et al. Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. Diabetes. 2006;55:3180-3184.
36. Londos C, Brasaemle DL, Gruia-Gray J, et al. Perilipin: unique proteins associated with intracellular neutral lipid droplets in adipocytes and steroidogenic cells. Biochem Soc Trans. 1995;23:611-615.
37. Liang J, Fu M, Ciociola E, et al. Role of ENPP1 on adipocyte maturation. PLoS One. 2007;2:e882.
38. Pan W, Ciociola E, Saraf M, et al. Metabolic consequences of ENPP1 overexpression in adipose tissue. Am J Physiol Endocrinol Metab. 2011;301:E901-E911.
39. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006;64:355-365.
40. Lazzeroni LC, Ray A. The cost of large numbers of hypothesis tests on power, effect size and sample size. Mol Psychiatry. 2012;17:108-114.